×
Close
註冊
登入
主页
用户
博客
照片
视频
医学图书S馆
医学图书M馆
医学图书D馆
医学术语
群组
活动
用户工具
用户指南
问答
谁看过我
反馈
语言
English
中文
推广
所有
MeSH descriptor
Mesh Subheading
Mesh Supplementary Concept
Mesh Pharmacological Action
search
搜索
清除所有
MeSH 搜索器
AND
OR
加入MeSH搜索引擎
搜索PubMed论文列
清除所有
Communicable Disease Control
Programs of surveillance designed to prevent the transmission of disease by any means from person to person or from animal to man.
推出的年份:
副标题
economics
history
instrumentation
legislation and jurisprudence
methods
organization and administration
standards
statistics and numerical data
trends
树号:
N06.850.780.200
MeSH 单一 ID:
D003140
进入的组:
Control, Communicable Disease
Parasite Control
Control, Parasite
Flattening the Curve, Communicable Disease Control
Flatten the Curve of Epidemic
All MeSH Categories
Health Care Category
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Communicable Disease Control [N06.850.780.200]
Animal Culling [N06.850.780.200.112]
Contact Tracing [N06.850.780.200.225]
Disease Notification [N06.850.780.200.262]
Fumigation [N06.850.780.200.300]
Immunization [N06.850.780.200.425]
add_circle
Infection Control [N06.850.780.200.450]
add_circle
Mandatory Testing [N06.850.780.200.550]
Mass Drug Administration [N06.850.780.200.600]
Pest Control [N06.850.780.200.650]
add_circle
Physical Distancing [N06.850.780.200.688]
Quarantine [N06.850.780.200.725]
Sanitation [N06.850.780.200.800]
add_circle
Universal Precautions [N06.850.780.200.925]
Decontamination [N06.850.780.325]
Environmental Monitoring [N06.850.780.375]
add_circle
Mass Screening [N06.850.780.500]
add_circle
Medical Countermeasures [N06.850.780.588]
Population Surveillance [N06.850.780.675]
add_circle
Primary Prevention [N06.850.780.680]
add_circle
Quaternary Prevention [N06.850.780.715]
Secondary Prevention [N06.850.780.750]
Tertiary Prevention [N06.850.780.800]
thumb_up
Like
share
分享
favorite
书签
0
0
0
0
0
0
0
留言 (
0
)
gif
登入或註冊以發表你的留言
Modal title
×
Modal title
×
分享
登入
Global News and Health Forum
Join Now!
馬上登入
記住我
忘記密碼?
或者使用
Linkedin
留言 (0)